Share On Social!
Doctors often have implicit, subconscious preferences for white patients over those of color, studies show. This is implicit bias. These biases — stereotypes that affect our understanding and decisions about others beyond our conscious control — lead to discrimination and health disparities.
To address this issue, you’re invited to join us for “Overcoming Implicit Bias in the Doctor’s Office and Research Studies,” at 2 p.m. CT on April 25, 2022.
This is the third webinar of a new series, “Let’s Address Health Equity Together.”
This Zoom webinar will feature guest speakers to help health care professionals understand implicit bias, “rewire” it toward compassion for patients and research participants of color and engage local leaders in implementing implicit bias training on a greater scale.
Update 4/27/22: 168 registered to attend this webinar. Watch the recording!
Learn about the Webinar Panelists on Implicit Bias
On April 25, 2022, panelists Dr. Chiquita Collins, Dr. Jabraan Pasha, and Loriana Hernandez-Aldama will present on how physicians can overcome implicit bias and identify ways to improve the patient experience in the doctor’s office, with a discussion and question-and-answer session moderated by Dr. Amelie Ramirez.
Dr. Amelie G. Ramirez, an internationally recognized researcher in Latino health promotion and behavioral change, is director of Salud America! and its home base, the Institute for Health Promotion Research in the Department of Population Health Sciences at UT Health San Antonio. She has spent over 30 years directing research on human and organizational communication to reduce chronic disease and cancer health disparities affecting Latinos, including cancer risk factors, clinical trial recruitment, tobacco prevention, obesity prevention, and promotion of health equity. She also is associate director of cancer outreach and engagement at the NCI-designated Mays Cancer Center at UT Health San Antonio.
Rachel Israel is the Director of Regional Patient Advocacy Relations for Genentech. She and her team work with regional and local patient advocacy groups that are serving communities across the nation. She is passionate about health equity and equal access to health care for all patients. Rachel has been with Genentech for 15 years in various roles in the Oncology, Rare Disease and Immunology therapeutic areas. Previously, Rachel worked in hospital administration for Rehabilitation Hospitals. Her nonprofit background includes the American Red Cross and the National Marrow Donor Program, where she was recognized for her efforts in increasing marrow donations in minority communities.
Dr. Chiquita Collins has been actively involved in national and regional organizations in various leadership roles to advance diversity, equity, and inclusion. She has more than 25 years of experience in race relations and social epidemiology, research and practice; serves as chair of the Association of American Medical Colleges (AAMC) Group on Diversity and Inclusion (2021-2023), immediate past chair of Texas Medical Schools Diversity Consortium (2020-2021), Steering Committee Member, AAMC Group on Women in Medicine and Science Member (2013-2018); appointed Board Member, National Diversity Council Healthcare and Time’s UP Healthcare.
Dr. Jabraan Pasha is a physician-activist who is working to save lives by focusing on factors beyond the bedside that impact community health. A native of Tulsa, OK. he received his medical degree from The University of Kansas School of Medicine and completed his Internal Medicine Residency Training at Mayo Clinic Arizona. Dr. Pasha is an Associate Professor in the department of Internal Medicine at OU Health Physicians and the Assistant Dean of Student Affairs in the OU-TU School of Community Medicine in Tulsa. One of his major academic interests is the impact of implicit bias on patient care and society. He has presented his workshop Unlocking Implicit Bias over 100 times, including sessions for the American Association of Medical Colleges (AAMC), Mayo Clinic, and internationally in Paris, France, Porto, Portugal and most recently in Ottawa, Canada.
Loriana Hernandez-Aldama is an Emmy award-winning journalist, international speaker, 2x cancer survivor and author of Becoming the Story: The Power of PREhab. She is a powerhouse motivational speaker and gifted storyteller who inspires audiences and compels action with her 3P protocol to make more patients POSSIBLE. Bold, transparent and honest, Loriana has become a game-changer in the healthcare and wellness space by sharing the biggest story of her 25 year tv career and what she discovered when the script was flipped and she went from network medical reporter to the other side of healthcare after a diagnosis of AML Leukemia in 2014. Loriana is the Founder of ArmorUp for LIFE, a non-profit focused on amplifying the patient voice, bridging the gap in health disparities in communities of color and PREHAB for risk reduction.
Behind the Webinar Series on Health Equity
The “Let’s Address Health Equity Together” webinar series is a collaboration of the Salud America! program at the Institute for Health Promotion Research at UT Health San Antonio, the Mays Cancer Center at UT Health San Antonio, and Genentech.
Salud America! is a national Latino-focused organization that creates culturally relevant and research-based stories, videos, and tools to inspire people to start and support healthy changes to policies, systems, and environments where Latino children and families can equitably live, learn, work, and play.
The Mays Cancer Center, also known as the UT Health San Antonio MD Anderson Cancer Center, has a mission to decrease the burden of cancer in San Antonio, South Texas and beyond. We bring South Texas a level of exceptional care that is comparable with the nation’s most respected programs. More patients put their trust in our program because we have a unique understanding of our community’s cancer care needs. We excel in delivering advanced therapies.
Founded more than 40 years ago as the first biotechnology company, Genentech is dedicated to the rigorous pursuit of science and the development and delivery of life-changing medicines for people facing serious diseases. Headquartered in South San Francisco, California and a proud member of the Roche Group, our community is united by a common purpose and sense of urgency to transform the future of healthcare. Learn more at gene.com.